Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Pain, Postoperative 4Pancreatic Neoplasms 2Lung Neoplasms 2Liver Neoplasms 2Agnosia 2Uterine Cervical Neoplasms 1Thoracic Neuritis 1Stomach Neoplasms 1Reperfusion Injury 1Prostatic Neoplasms 1Neoplasms 1Leiomyoma 1Inflammation 1Endometrial Neoplasms 1End Stage Liver Disease 1Colonic Neoplasms 1Breast Neoplasms 1Breast Cancer Female 1Bites and Stings 1Adenomyosis 1Acute Pain 1

Interventions

Cyclophosphamide 361Trastuzumab 352Paclitaxel 304Docetaxel 272Capecitabine 222Letrozole 221Carboplatin 185Doxorubicin 181Tamoxifen 157Radiotherapy 154Epirubicin 145Fulvestrant 143Anastrozole 139Surveys and Questionnaires 133Exercise 128pertuzumab 113Vinorelbine 110Blood Specimen Collection 109exemestane 106palbociclib 104Bevacizumab 104pembrolizumab 98Magnetic Resonance Spectroscopy 97Albumin-Bound Paclitaxel 87Gemcitabine 84Drug Therapy 83Lapatinib 78130-nm albumin-bound paclitaxel 72Neoadjuvant Therapy 71Cisplatin 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Breast Neoplasms × Analgesia, Patient-Controlled × Clear all
NCT04726878 2021-11-09

ESP in Breast Surgery Due to Cancer

Medical University of Lublin

Phase 4 Completed
75 enrolled
Breast

Breast Neoplasms, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡